Sanofi intends to sell its equity investment in Regeneron; confirms no change to ongoing collaboration

You Are Here : Home Sanofi intends to sell its equity investment in Regeneron; confirms no change to ongoing collaboration

Sanofi intends to sell its equity investment in Regeneron; confirms no change to ongoing collaboration
May, 2620

Sanofi announced its intent to sell its equity investment in Regeneron (NASDAQ: REGN) through a registered public offering and related share repurchase by Regeneron. The registered offering and share repurchase will have no impact on the ongoing collaboration between Sanofi and Regeneron

Leave a Reply

Your email address will not be published.

Recent News

Goro Healthcare partners with Demophorius in the UAE and Qatar
December,321

Goro Healthcare launches Neopausil® in the United Arab Emirates
July,321

Tanyx® obtain MOHAP registration approval
January,1021

Goro Healthcare signs an exclusive distribution agreement with The OTClab and Perfect Care Phamra
September,820

Preliminary results from Russian trials find that vaccine candidates led to no serious adverse events and elicit antibody response
September,420

FDA announces first of its kind program to communicate patient reported outcomes from oncology clinical trials
July,120
TOP
0
    0
    Your Cart
    Your cart is empty
    Continue Shopping